More on TRDA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1.9% Growth)
- Ratings (7.5 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Entrada Therapeutics (NQ:TRDA)
Delayed: 7.09 +0.28 (4.11%)
Prev. Close $6.81  
Open$6.99 
52 Wk High$ 
52 Wk Low$ 
Day High$7.21 
Day Low$6.76 
P/E N/A  
EPS$ 
Volume339,761 

Friends, Peers and Foes (?): BIIB, AMLX, ANAB, ARWR, DRUG (more...)

Jun 12, 2026 05:35 PM Form 4 Entrada Therapeutics, For: Jun 10 Filed by: PARMAR KUSH
Jun 12, 2026 05:17 PM Form 4 Entrada Therapeutics, For: Jun 10 Filed by: KIM PETER S
Jun 12, 2026 05:17 PM Form 4 Entrada Therapeutics, For: Jun 10 Filed by: Chapman Gina
Jun 12, 2026 05:06 PM Form 4 Entrada Therapeutics, For: Jun 10 Filed by: Radhakrishnan Maha
Jun 12, 2026 05:01 PM Form 4 Entrada Therapeutics, For: Jun 10 Filed by: Thistle Mary
Jun 12, 2026 04:52 PM Form 4 Entrada Therapeutics, For: Jun 10 Filed by: Zeiher Bernhardt G
Jun 10, 2026 04:06 PM Form 8-K Entrada Therapeutics, For: Jun 10
Jun 8, 2026 06:51 AM Entrada Therapeutics (TRDA) PT Lowered to $17 at Guggenheim
Jun 5, 2026 02:14 PM Entrada Therapeutics (TRDA) PT Lowered to $17 at Guggenheim
Jun 2, 2026 07:03 AM Entrada Therapeutics receives approval to increase drug dose in DMD trial
View All Articles

Entities mentioned with TRDA

View All Entities